The Judy Lieberman group demonstrated that GSDME function was reduced in 20 of 22 tested cancer-associated GSDME mutation.1 Zhang et al. addressed the issue of GSDME function in tumour treatment in vitro and in vivo. This evidence concerns the gene GSDME and neoplasm.